Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 3023
  • Home
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes

Thomas R, Parikh R, Muliyil J, George R, Paul P, Abraham Lekha M

Year : 2003| Volume: 51| Issue : 2 | Page no: 123-128

   This article has been cited by
 
1 Patient persistence with first-line antiglaucomatous monotherapy
Arias, A., Schargel, K., Ussa, F., Canut, M.I., Robles, A.B., Sánchez, B.M.
Clinical Ophthalmology. 2010; 4(1): 261-267
[Pubmed]  [Google Scholar]
2 Reporting of noninferiority and equivalence randomized trials for major prostaglandins: A systematic survey of the ophthalmology literature
Eyawo, O., Lee, C.-W., Rachlis, B., Mills, E.J.
Trials. 2008; 9(Art 69)
[Pubmed]  [Google Scholar]
3 Persistence and adherence with topical glaucoma therapy
Nordstrom, B.L., Friedman, D.S., Mozaffari, E., Quigley, H.A., Walker, A.M.
American Journal of Ophthalmology. 2005; 140(4): 598 e 1-598 e 11
[Pubmed]  [Google Scholar]
4 Latanoprost or brimonidine as treatment for elevated intraocular pressure: Multicenter trial in the United States
Camras, C.B., Sheu, W.-P.
Journal of Glaucoma. 2005; 14(2): 161-167
[Pubmed]  [Google Scholar]
5 Glaucoma management in developing countries: Medical, laser, and surgical options for glaucoma management in countries with limited resources
Thomas, R., Sekhar, G.C., Kumar, R.S.
Current Opinion in Ophthalmology. 2004; 15(2): 127-131
[Pubmed]  [Google Scholar]

 

Read this article